Dr. Jing Yang is a Professor of Pharmacology at the Univ. of California, San Diego and the co-Leader of the Cancer Biology and Signalling Program at Moores Cancer Center. She obtained her PhD in Molecular Cancer Biology with Dr. Sally Kornbluth at Duke University in 1999. Her research aims to elucidate the molecular basis of tumor metastasis and to identify new therapeutic targets. Her laboratory combines cell and molecular biology tools, mouse tumor models, 3D organoids culture, functional genomics, and 2D/3D imaging techniques to uncover the genes and the signalling pathways responsible for tumor metastasis. Her group has identified invadopodia-mediated extracellular matrix degradation, matrix stiffening, and epithelial polarity as being critical regulatory mechanisms of EMT and tumor metastasis and continues to address the dynamic involvement of these programs in metastasis. To Longaevus, Jing Yang, as a Scientific Advisor, brings years of experience in pharmacology and new discoveries in the role of extracellular matrix (ECM) in the aging process. Dr. Yang’s achievements are recognised by many awards, such as NIH Director’s New Innovators Award and American Cancer Society Research Scholar.